Genzyme May Sell Off Noncore Businesses; Will Disclose Unit Detail


Published On: April 28th, 2010

CEO Henri Termeer says Icahn is heavily invested in Biogen Idec and is already on “way too many boards.”

See original here:
Genzyme May Sell Off Noncore Businesses; Will Disclose Unit Detail



Loading...


Comments are closed.